SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-22-007683
Filing Date
2022-03-30
Accepted
2022-03-30 16:17:57
Documents
11
Period of Report
2022-05-11

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A nby20220324_def14a.htm DEF 14A 569042
2 a01.jpg GRAPHIC 779
3 a02.jpg GRAPHIC 7452
4 a03.jpg GRAPHIC 7697
5 a04.jpg GRAPHIC 22971
6 a05.jpg GRAPHIC 794
7 a06.jpg GRAPHIC 11511
8 card01.jpg GRAPHIC 141574
9 card02.jpg GRAPHIC 108013
10 logo01.jpg GRAPHIC 9343
11 sig01.jpg GRAPHIC 8243
  Complete submission text file 0001437749-22-007683.txt   1009336
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33678 | Film No.: 22786692
SIC: 2834 Pharmaceutical Preparations